Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,520.36
(
0.02%
)
US TECH 100
29,106.40
(
-0.25%
)
Dow Jones
50,644.28
(
0.36%
)
Brent Oil
93.90
(
1.58%
)
Bitcoin
73,383.04
(
-2.01%
)
News Focus
News Focus

Replies to post #59 on Summit Therapeutics Inc (SMMT)

Replies to #59 on Summit Therapeutics Inc (SMMT)
icon url

crudeoil24

12/06/22 4:33 PM

#60 RE: subslover #59

Congrats! Nice run on todays news.
Summit Therapeutics announced a definitive agreement of its partnership with Akeso to in-license its breakthrough bispecific antibody, ivonescimab.